This content is from: Premium
Biotech SPAC Mergers Rock These Hedge Funds
Many of the collapsing stocks are among their largest holdings.
Another day, another sharp selloff for a biotech company that recently merged with a blank-check company.On Friday, shares of Greenlight Biosciences Holdings fell more than 16 percent. The company, which develops RNA products for agriculture and human health, went public February 4 after completing its merger with SPAC Environmental Impact
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.